Pennsylvania SB 675: An Act providing for certification of buprenorphine office-based prescribers; limiting the use of buprenorphine; and imposing powers and duties on the Department of Drug and Alcohol Programs.

Status: Referred to HUMAN SERVICES (as of 2019-06-18)

State: Pennsylvania · Session: 2019-2020 · Bill: SB 675

Sponsors: Brooks, Browne, Folmer, Hutchinson, K. Ward, Killion, Stefano

View Pennsylvania SB 675 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.